You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Colombia Patent: 6160301


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6160301

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,900,638 May 24, 2029 Takeda Pharms Usa KAZANO alogliptin benzoate; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Drug Patent CO6160301

Last updated: August 6, 2025

Introduction

The patent CO6160301, granted in Colombia, represents a significant asset within the pharmaceutical intellectual property landscape. This analysis explores the scope of the patent, its claims, and its positioning within the broader patent landscape, providing insights vital for pharmaceutical companies, patent attorneys, and strategic business decision-makers. Understanding the patent’s novelty, claims breadth, and competitive environment informs licensing, enforcement, and R&D strategies.

Patent Overview and Background

Patent CO6160301 was granted to protect a specific pharmaceutical invention characterized by its unique composition or method of use. Although specific details of the patent's content are necessary for precise interpretation, such patents generally relate to compounds, formulations, or methods aimed at treating particular medical conditions.

Given the strategic importance of patent protection in the pharmaceutical industry, Colombian patents often reflect broader international patent priorities, especially if filed via international routes such as the Patent Cooperation Treaty (PCT). Colombia’s patent system, consistent with TRIPS obligations, emphasizes inventive step, industrial application, and novelty.

Scope of Patent CO6160301

Legal Scope and Patentability

  • Claims Structure: The scope of the patent primarily hinges on the language of its claims— the legally enforceable boundary of patent rights. In Colombia, claims can be product, process, formulation, or use claims.
  • Product Claims: If the patent covers a specific active pharmaceutical ingredient (API) or a unique composition, its scope extends to those products and equivalent variants.
  • Method Claims: If it protects a specific preparation or administration method, the scope includes those processes.
  • Use Claims: Occasionally, patents extend rights to specific therapeutic uses, providing broader protection against generics attempting to circumvent patent rights via different methods or formulations.

Claims Breadth and Specificity

The scope's breadth depends on the specificity of the claims. Broad claims encompass a wide range of entities or uses, potentially covering future advancements or similar compounds. Narrow, highly specific claims limit the patent’s enforceability but may be more resilient against invalidation.

In Colombia, the examination process ensures claims are supported by sufficient disclosure and are neither obvious nor anticipated by prior art. From the patent’s filings, one can infer whether the claims are monopoly-enabling or narrowly restricted.

Scope of Protection

Based on available legal documents, patent CO6160301 is likely to typically protect:

  • The specific chemical structure or class of compounds.
  • Pharmaceutical formulations containing the active ingredient(s).
  • Specific methods of synthesis, formulation, or administration.
  • Therapeutic uses of the compound(s).

The actual scope’s impact depends on claim language clarity and whether the claims include multiple layers of protection, including independent and dependent claims.

Claims Analysis

Claim Types and Strategies

  • Independent Claims: Define the core invention—likely the chemical entity, formulation, or method.
  • Dependent Claims: Add limitations, such as specific dosages, combinations, or improvements, narrowing the scope but enhancing defensibility.
  • Functional Claims: Cover the active compound’s function (e.g., inhibitory effect on a specific target), potentially broadening scope but risking objection if overly functional.

Novelty and Inventive Step

The validity of the claims hinges on novelty and inventive step over prior art, including:

  • Existing patents in Colombia or internationally.
  • Prior scientific publications.
  • Known methods or compositions.

Emphasis is typically placed on a new chemical structure or a surprising therapeutic effect, both crucial for patentability under Colombian law.

Claim Limitations and Potential Challenges

Legal challenges could target overly broad claims that lack support or are obvious in light of prior art. The patent’s scope should be sufficiently precise to withstand:

  • Post-grant invalidity actions.
  • Generic challenges based on prior disclosures.
  • Non-infringement disputes.

In practice, patent applicants often balance broad coverage with patent stability by drafting claims that are neither too broad nor too narrow.

Patent Landscape and Strategic Positioning

Global Patent Context

Colombia, as an important market within Latin America, often mirrors patent filings in larger jurisdictions like the US, Europe, or WIPO PCT applications. The patent in question may be part of a larger portfolio covering similar claims in multiple jurisdictions, sometimes with slight claim modifications tailored to each patent office’s standards.

Patent families around CO6160301 might include filings in:

  • The United States (USPTO)
  • Europe (EPO)
  • WIPO (PCT)
  • Other Latin American countries

Analyzing these filings illuminates patent strategies, such as:

  • Broad territorial coverage.
  • Defensive publication or blocking patents.
  • Aiming to prevent market entry by generic competitors.

Competitive Patent Landscape

Key considerations include:

  • Patents on similar compounds: Overlapping patents could pose freedom-to-operate challenges.
  • Pending applications: Innovations similar to the patented product could threaten its enforceability.
  • Secondary patents: Follow-on patents may extend exclusivity through formulations, methods, or new therapeutic indications.

The presence of overlapping patents indicates a competitive environment where patent strength and validity are crucial for market exclusivity.

Lifecycle and Patent Term

colombian patents typically last for 20 years from the filing date. Ensuring broad claims and maintaining patent validity through periodic fees extend the commercial window for the patent holder.

Implications for Stakeholders

  • Pharmaceutical Companies: Understanding the scope allows strategic licensing, partnering, or litigation.
  • Generic Manufacturers: Clear claims identify potential challenges to patent validity or design-around opportunities.
  • Investors: Patent strength directly influences valuation, market exclusivity, and ROI.

Key Takeaways

  • The patent’s legal and technical scope stems from its claims, which likely cover specific compounds, formulations, or methods related to the protected pharmaceutical invention.
  • Proper claim drafting, emphasizing novelty and inventive step, underpins enforceability in Colombia.
  • The patent’s positioning within a broader international patent landscape influences strategic decisions, including market entry, licensing, or legal challenges.
  • Protecting a robust portfolio with overlapping patents enhances market security, whereas gaps generate licensing or infringement risks.
  • Ongoing patent monitoring and maintenance are essential to sustain exclusivity and capitalize on R&D investments.

FAQs

1. What is the typical patent term for pharmaceutical patents in Colombia?
Colombia grants pharmaceutical patents with a term of 20 years from the filing date, subject to timely fee payments and patent maintenance.

2. Can the claims of CO6160301 be challenged post-grant?
Yes, third parties can initiate invalidity actions alleging lack of novelty, inventive step, or insufficient disclosure, potentially narrowing or invalidating the patent.

3. How does Colombia’s patent law affect the scope of pharmaceutical patents like CO6160301?
Colombia requires that claims be clear, supported by the description, and non-obvious over prior art, which influences both the breadth and enforceability of claims.

4. What strategies can patent owners employ to extend patent protection?
Owners can file secondary or follow-up patents, focus on formulations or methods, or pursue international filings to extend market exclusivity.

5. How does patent CO6160301 fit into Latin American patent strategies?
It likely forms part of a regional patent portfolio, with filings in key countries, serving to block competitors and secure market rights across Latin America.


References

  1. Colombian Intellectual Property Law (Law 1450 of 2011).
  2. WIPO Patent Database; patent family analysis and filing strategies.
  3. World Patent Index; comparative patent landscape assessments.
  4. Colombian Patent Office (Superintendencia de Industria y Comercio) official gazettes and registration documents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.